The use of navoban in the therapy of oncology patients with highly emetic treatments
Russel, A.J.
Voprosy Onkologii 41(1): 87-90
1995
ISSN/ISBN: 0507-3758 PMID: 7667952 Document Number: 442017
Document emailed within 1 workday
Related Documents
Mosam, A.; Shaik, F.; Uldrick, T.S.; Esterhuizen, T.; Friedland, G.H.; Scadden, D.T.; Aboobaker, J.; Coovadia, H.M. 2012: A Randomized Controlled Trial of Highly Active Antiretroviral Therapy Versus Highly Active Antiretroviral Therapy and Chemotherapy in Therapy-Naive Patients With HIV-Associated Kaposi Sarcoma in South Africa Journal of Acquired Immune Deficiency Syndromes (1999) 60(2): 150-157Mosam, A.; Shaik, F.; Uldrick, T.S.; Esterhuizen, T.; Friedland, G.H.; Scadden, D.T.; Aboobaker, J.; Coovadia, H.M. 2012: A Randomized Controlled Trial of Highly Active Antiretroviral Therapy Versus Highly Active Antiretroviral Therapy and Chemotherapy in Therapy-Naive Patients With HIV-Associated Kaposi Sarcoma in South Africa Journal of Acquired Immune Deficiency Syndromes (1999) 60(2): 150-157
Sulaiman, M.M.; Shettima, J.; Ummate, I.; Arogundade, F.A.; Yusuph, H.; Nwankwo, E.; Sanusi, A.A.; Akinsola, A. 2022: Comparative Evaluation of Prevalence, Risk Factors, and Pathologic Features of Kidney Disease in Highly Active Antiretroviral Therapy-Naive and Highly Active Antiretroviral Therapy-Experienced Patients at a Tertiary Health Facility in Maiduguri, Northeastern Nigeria Saudi Journal of Kidney Diseases and Transplantation: An Official Publication of the Saudi Center for Organ Transplantation Saudi Arabia 33(1): 72-79
Leichman, L.; Steiger, Z.; Seydel, H.G.; Vaitkevicius, V.K. 1984: Combined preoperative chemotherapy and radiation therapy for cancer of the esophagus: the Wayne State University, Southwest Oncology group and Radiation Therapy Oncology Group experience Seminars in Oncology 11(2): 178-185
2014: Oncology and haematology in 2013. Some advances, but too many new treatments with an inadequately assessed harm-benefit balance Prescrire International 23(148): 103-105
Idiculla, J. 2011: Anthropometric changes in patients receiving highly active antiretroviral therapy (ART) Journal of the Association of Physicians of India 59: 530; Author Reply 530
Regidor, P.A.; Nelken, B.; Regidor, M.; Bier, U.; Oberhoff, C.; Schindler, A.E. 1996: Effectiveness and tolerance of Navoban (5HT3-receptor antagonist tropisetron) in prevention of cytostatic drug-induced nausea and vomiting in patients with breast carcinomas and gynecological malignancies Zentralblatt für Gynakologie 118(3): 148-153
Diago, M.és. 2005: Alternative treatments for patients with chronic C hepatitis who did not respond previous treatments Revista de Gastroenterologia de Mexico 70(4): 458-464
Deng, X.-j.; He, Y.; Yang, L.; Zou, S.-p.; Yang, H.; Zheng, Y.-h. 2011: The evaluation of four-year highly active antiretroviral therapy in HIV-1 infected patients Zhonghua Nei Ke Za Zhi 50(3): 230-234
Zubova, N.D.; Bardychev, M.S.; Guseva, L.I. 1981: Use of needle reflex therapy in the treatment of the pain syndrome of oncology patients Vestnik Akademii Meditsinskikh Nauk SSSR 8: 87-90
Silveira, M.P.T.; Guttier, M.íl.C.; Pinheiro, C.A.T.; Pereira, T.V.S.; Cruzeiro, A.L.S.; Moreira, L.B. 2012: Depressive symptoms in HIV-infected patients treated with highly active antiretroviral therapy Revista Brasileira de Psiquiatria 34(2): 162-167
Mohammadpour, A.; Yekta, Z.P.; Nikbakht Nasrabadi, A.R. 2010: HIV-infected patients' adherence to highly active antiretroviral therapy: a phenomenological study Nursing and Health Sciences 12(4): 464-469
Bachur, T.Paschoalette.Rodrigues.; Vale, J.Martins.; Coêlho, I.Castelo.Branco.; Queiroz, T.Régia.Bezerra.Sales.de.; Chaves, C.de.Souza. 2008: Enteric parasitic infections in HIV/AIDS patients before and after the highly active antiretroviral therapy Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases 12(2): 115-122
Domingos, H.; Cunha, R.V.ân.d.; Paniago, A.M.M.; Martins, D.M.; Elkhoury, E.B.ão.; Souza, A.S.d. 2009: Metabolic effects associated to the highly active antiretroviral therapy (HAART) in AIDS patients Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases 13(2): 130-136
Pinto, J.L.; López Lavid, C.; Badia, X.; Coma, A.; Benavides, A. 2000: Cost effectiveness analysis of highly active antiretroviral therapy in HIV asymptomatic patients Medicina Clinica 114(Suppl 3): 62-67
Bachur, T.Paschoalette.Rodrigues.; Vale, J.Martins.; Coêlho, I.Castelo.Branco.; Queiroz, T.Régia.Bezerra.Sales.de.; Chaves, C.de.Souza. 2008: Enteric parasitic infections in HIV/AIDS patients before and after the highly active antiretroviral therapy Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases 12(2): 115-122
Fox, R.; Gourlay, Y.J. 2000: The impact of highly active antiretroviral combination therapy in HIV infected patients in Glasgow Health Bulletin 58(4): 309-315
Sevastianova, K.; Sutinen, J.; Westerbacka, J.; Ristola, M.; Yki-Järvinen, H. 2005: Arterial stiffness in HIV-infected patients receiving highly active antiretroviral therapy Antiviral Therapy 10(8): 925-935
Jáuregui Camargo, L.; Ruiz-Palacios, G.; Guerrero Almeida, L.; Niño Oberto, S.; Peasey, A.; Sierra Madero, J. 2003: Evaluation of highly active antiretroviral therapy (HAART) in a cohort of patients with HIV infection in Mexico Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 55(1): 10-17
Pomerantz, R.J. 1999: HIV patients receiving HAART therapy can still transmit the virus. Highly active antiretroviral chemotherapy American Family Physician 59(10): 2855